BDH Industries

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE278D01018
  • NSEID:
  • BSEID: 524828
INR
407.00
14.4 (3.67%)
BSENSE

Jan 19

BSE+NSE Vol: 21.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

21.26 k (360.76%) Volume

Shareholding (Sep 2025)

FII

0.28%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

49.70%

When is the next results date for BDH Industries?

06-Jun-2025

No Upcoming Board Meetings

Who are in the management team of BDH Industries?

06-Jun-2025

As of March 2023, the management team of BDH Industries includes Jayashree Nair (Chairperson & Managing Director), S C Kachhara (Joint Managing Director & CFO), Karthika Nair (Director), and several independent directors, including Dinesh Variar, Bhagirath Singh Sihag, and Kairav Trivdi, along with Nikita Phatak (Company Secretary & Compliance Officer). This team oversees the company's operations and strategic direction.

As of March 2023, the management team of BDH Industries includes the following individuals:<BR><BR>1. Jayashree Nair - Chairperson & Managing Director<BR>2. S C Kachhara - Joint Managing Director & CFO<BR>3. Karthika Nair - Director<BR>4. Dinesh Variar - Independent Director<BR>5. Bhagirath Singh Sihag - Independent Director<BR>6. Nikita Phatak - Company Secretary & Compliance Officer<BR>7. Kairav Trivdi - Independent Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

View full answer

What does BDH Industries do?

06-Jun-2025

BDH Industries Ltd is a micro-cap pharmaceutical and biotechnology company that manufactures various drug formulations, primarily in the antibiotic, anti-inflammatory, and anti-microbial segments. As of March 2025, it reported net sales of 18 Cr and a net profit of 2 Cr, with a market cap of Rs 144 Cr.

Overview:<BR>BDH Industries Ltd is a pharmaceutical and biotechnology company engaged in the manufacturing of a wide range of drug formulations, primarily in the antibiotic, anti-inflammatory, and anti-microbial segments, classified as a micro-cap company.<BR><BR>History:<BR>Incorporated in 1990, BDH Industries was converted into a public limited company in 1994 after amalgamating with Bombay Drug House Pvt Ltd. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 18 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 2 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 144 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 16.00<BR>- Industry P/E: 35<BR>- Dividend Yield: 1.75%<BR>- Debt Equity: -0.37<BR>- Return on Equity: 14.60%<BR>- Price to Book: 2.33<BR><BR>Contact Details:<BR>Address: Nair Baug, Akurli Road Kandivli (E) Mumbai Maharashtra : 400101<BR>Tel: 91-22-28871370/28870834<BR>Email: comp.sec@bdhind.com<BR>Website: http://www.bdhind.com

View full answer

Has BDH Industries declared dividend?

06-Jun-2025

Yes, BDH Industries has declared a dividend of 45% (4.5 per share) with an ex-date of August 2, 2024. While recent returns have been negative, the company has shown significant growth over longer periods, with a total return of 328.51% over the past 5 years.

BDH Industries has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 45%<BR>- Amount per share: 4.5<BR>- Ex-date: 02 Aug 24<BR><BR>Dividend Yield: 1.75%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.29%, with no dividend return, resulting in a total return of -30.29%.<BR><BR>Over the past year, the price return was -25.9%, with a dividend return of 1.29%, leading to a total return of -24.61%.<BR><BR>In the 2-year period, the price return was 73.18%, accompanied by a dividend return of 5.60%, culminating in a total return of 78.78%.<BR><BR>For the 3-year period, the price return was 103.04%, with a dividend return of 11.42%, resulting in a total return of 114.46%.<BR><BR>In the last 4 years, the price return was 151.38%, with a dividend return of 13.95%, leading to a total return of 165.33%.<BR><BR>Over the past 5 years, the price return was 302.98%, with a dividend return of 25.53%, resulting in a total return of 328.51%.<BR><BR>Overall, BDH Industries has declared a significant dividend, and while the recent returns over shorter periods show negative performance, longer-term returns reflect substantial growth, particularly in price returns.

View full answer

Who are the peers of the BDH Industries?

03-Jun-2025

BDH Industries' peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Lactose (India), Welcure Drugs, Sotac Pharma, and Vaishali Pharma. Among these, Sun Pharma and Cipla show excellent management and growth, while Lactose (India) has the lowest 1-year return at -35.55%, compared to BDH Industries' -25.45%.

Peers: The peers of BDH Industries are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Lactose (India), Welcure Drugs, Sotac Pharma., and Vaishali Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, and BDH Industries, while Below Average management risk is found at Lactose (India), Welcure Drugs, Sotac Pharma., and Vaishali Pharma. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is noted for Divi's Lab., BDH Industries, Torrent Pharma, Lactose (India), and Vaishali Pharma. Excellent capital structure is seen at Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, and BDH Industries, while Below Average capital structure is present at Lactose (India), Welcure Drugs, and Vaishali Pharma.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Divi's Lab. at 51.69%, while the peer with the lowest is Lactose (India) at -35.55%. BDH Industries has a 1-year return of -25.45%, which is better than Lactose (India) but worse than Divi's Lab. Additionally, Lactose (India), BDH Industries, and Vaishali Pharma have negative six-month returns.

View full answer

What is the technical trend for BDH Industries?

09-Jun-2025

As of June 6, 2025, BDH Industries is in a bearish trend with moderate strength, supported by bearish MACD and moving averages, while mixed signals from KST and Bollinger Bands indicate a lack of clear direction.

As of 6 June 2025, the technical trend for BDH Industries has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. The weekly MACD is bearish, and daily moving averages confirm a bearish trend. While the monthly MACD is mildly bearish, the Bollinger Bands indicate a mildly bearish outlook on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, suggesting mixed signals. Overall, the lack of clear trends in Dow Theory and the absence of signals from the RSI further support the bearish sentiment.

View full answer

Who are the top shareholders of the BDH Industries?

17-Jul-2025

The top shareholders of BDH Industries are Jayashree Nair with 21.83%, Vramath Financial Services Pvt Ltd at 5.59%, and individual investors holding 29.02%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of BDH Industries include Jayashree Nair, who holds the highest promoter stake at 21.83%. The highest public shareholder is Vramath Financial Services Pvt Ltd, with a holding of 5.59%. Additionally, individual investors collectively own 29.02% of the company. There is also one Foreign Institutional Investor (FII) that holds 0.28% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

View full answer

How big is BDH Industries?

24-Jul-2025

As of 24th July, BDH Industries Ltd has a market capitalization of 188.00 Cr, with recent net sales of 21.20 Cr and a net profit loss of 0.00 Cr. Shareholder's funds are at 68.76 Cr, and total assets amount to 86.94 Cr.

As of 24th July, BDH Industries Ltd has a market capitalization of 188.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest two quarters, BDH Industries reported Net Sales of 21.20 Cr. The Net Profit for the same period was recorded as a loss of 0.00 Cr.<BR><BR>The latest annual reporting period shows Shareholder's Funds at 68.76 Cr and Total Assets amounting to 86.94 Cr.

View full answer

Are BDH Industries latest results good or bad?

09-Aug-2025

BDH Industries' latest results show mixed performance: while net sales reached Rs 18.62 crore, the standalone net profit declined by 26.51%, raising concerns about profitability and operational efficiency. Overall, the cautious market sentiment suggests the results are not entirely favorable.

BDH Industries' latest results present a mixed picture. On one hand, the company achieved net sales of Rs 18.62 crore for the quarter ending June 2025, which is the highest quarterly sales in the last five quarters. This indicates a positive sales trend and suggests some stabilization in financial performance.<BR><BR>However, despite the increase in sales, the company has faced challenges, particularly in profitability. The standalone net profit saw a significant decline of 26.51% compared to the previous quarter, indicating that while sales are up, the overall financial health is not improving as expected. Additionally, the operating profit margin has also decreased, which raises concerns about cost management and operational efficiency.<BR><BR>Moreover, MarketsMOJO has issued a 'Sell' call on the stock, reflecting a cautious outlook on BDH Industries' performance. Overall, while there are positive sales figures, the decline in profit and the cautious market sentiment suggest that the results are not entirely favorable. Investors should keep a close watch on how the company addresses these challenges moving forward.

View full answer

How has been the historical performance of BDH Industries?

13-Nov-2025

BDH Industries has experienced a decline in net sales and profitability, with net sales dropping to 66.51 Cr in March 2025 from 85.83 Cr in March 2024. However, cash flow from operating activities improved to 14.00 Cr in March 2025, recovering from a negative cash flow the previous year.

Answer:<BR>The historical performance of BDH Industries shows a fluctuating trend in net sales and profitability over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>BDH Industries reported net sales of 66.51 Cr in March 2025, down from 85.83 Cr in March 2024 and 74.46 Cr in March 2023, indicating a downward trend in revenue. The total operating income mirrored this decline, falling to 66.51 Cr in March 2025 from 85.83 Cr in the previous year. The company's total expenditure also decreased to 54.90 Cr in March 2025, compared to 73.41 Cr in March 2024. Operating profit (PBDIT) was 13.45 Cr in March 2025, slightly lower than 14.00 Cr in March 2024, while profit before tax decreased to 12.47 Cr from 13.25 Cr. Profit after tax showed a similar trend, with 9.27 Cr in March 2025 compared to 9.87 Cr in March 2024. The company's total assets decreased to 86.94 Cr in March 2025 from 93.41 Cr in March 2024, and total liabilities also fell to 86.94 Cr from 93.41 Cr. Cash flow from operating activities improved to 14.00 Cr in March 2025, recovering from a negative cash flow of -1.00 Cr in March 2024, while the closing cash and cash equivalents increased to 31.00 Cr from 25.00 Cr. Overall, BDH Industries has experienced fluctuations in its financial metrics, with a recent decline in sales and profits but an improvement in cash flow.

View full answer

Should I buy, sell or hold BDH Industries?

15-Nov-2025

Is BDH Industries overvalued or undervalued?

04-Dec-2025

As of December 3, 2025, BDH Industries is fairly valued with a PE ratio of 21.85 and an EV to EBIT of 15.88, showing a strong long-term performance of 340.74% over five years, despite a recent dip of -12.74% compared to the Sensex.

As of 3 December 2025, BDH Industries has moved from an expensive to a fair valuation grade. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 21.85, an EV to EBIT of 15.88, and a ROCE of 32.27%. <BR><BR>In comparison to its peers, BDH Industries' PE ratio aligns closely with Cipla's at 22.39, while it is notably lower than Sun Pharma's expensive valuation at 37.51. Additionally, BDH's EV to EBITDA of 14.69 is more favorable compared to the higher ratios of its competitors, indicating a more attractive valuation. Despite a recent dip in stock performance compared to the Sensex, where BDH returned -12.74% over the past month against the Sensex's 1.34%, its long-term performance remains strong with a 340.74% return over five years.

View full answer

Why is BDH Industries Ltd falling/rising?

18-Jan-2026

As of 18-Jan, BDH Industries Ltd is experiencing a decline in its stock price to 390.60, down 2.35%. This decline is due to underperformance against its sector, a recent trend reversal, and negative short-term returns.

As of 18-Jan, BDH Industries Ltd is experiencing a decline in its stock price, currently at 390.60, which reflects a change of -9.4 or -2.35%. This drop can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has underperformed its sector by 1.24% today, indicating a relative weakness compared to its peers. Additionally, the stock has fallen after two consecutive days of gains, suggesting a trend reversal that may have contributed to the current decline. The intraday trading also showed volatility, with the stock reaching a high of Rs 413 but dropping to a low of Rs 385, indicating significant fluctuations in investor sentiment throughout the day.<BR><BR>Moreover, the stock's performance over the past week and month has been negative, with declines of 2.35% and 5.82%, respectively. Year-to-date, the stock is down 8.19%, which further reflects a bearish trend. While the stock has shown strong performance over the longer term, with a 15.91% increase over the past year and impressive gains over three and five years, the recent short-term performance suggests that investors may be reacting to current market conditions or specific company news that has not been detailed in the source data.<BR><BR>In summary, the combination of underperformance against the sector, a recent trend reversal, and negative short-term returns are key factors contributing to the falling stock price of BDH Industries Ltd.

View full answer

Which are the latest news on BDH Industries?

19-Jan-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

High Management Efficiency with a high ROE of 15.54%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 6.65% and Operating profit at 10.25% over the last 5 years

 
4

Flat results in Sep 25

 
5

With ROE of 13.8, it has a Expensive valuation with a 3.2 Price to Book Value

6

Majority shareholders : Non Institution

 
7

Consistent Returns over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 226 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.15%

stock-summary
Debt Equity

-0.51

stock-summary
Return on Equity

13.81%

stock-summary
Price to Book

3.18

Revenue and Profits:
Net Sales:
19 Cr
(Quarterly Results - Sep 2025)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.15%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.65%
0%
-12.65%
6 Months
35.67%
1.36%
37.03%
1 Year
18.69%
1.36%
20.05%
2 Years
70.69%
3.82%
74.51%
3 Years
166.36%
9.16%
175.52%
4 Years
173.71%
11.90%
185.61%
5 Years
375.19%
18.76%
393.95%

Latest dividend: 4.5 per share ex-dividend date: Aug-01-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Jan-2026 | Source : BSE

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2025 is enclosed herewith for reference.

Closure of Trading Window

26-Dec-2025 | Source : BSE

Intimation of Closure of Trading Window

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Dec-2025 | Source : BSE

Kindly find the enclosed herewith the Notice of special window for re-lodgement of transfer requests of physical shares published in newspapers - Free Press Journal (in English language) and Nav Shakti (in Marathi language) for your reference.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

BDH Industries Ltd has declared 45% dividend, ex-date: 01 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.65%
EBIT Growth (5y)
10.25%
EBIT to Interest (avg)
10.06
Debt to EBITDA (avg)
0.77
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
1.16
Tax Ratio
26.25%
Dividend Payout Ratio
26.25%
Pledged Shares
0
Institutional Holding
0.28%
ROCE (avg)
27.50%
ROE (avg)
15.54%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
3.18
EV to EBIT
16.95
EV to EBITDA
15.68
EV to Capital Employed
5.47
EV to Sales
2.64
PEG Ratio
23.06
Dividend Yield
1.15%
ROCE (Latest)
32.27%
ROE (Latest)
13.81%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.28%)

Promoter with highest holding

Jayashree Nair (21.83%)

Highest Public shareholder

None

Individual Investors Holdings

29.08%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 1.83% vs 4.49% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 43.17% vs -26.51% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.96",
          "val2": "18.62",
          "chgp": "1.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.33",
          "val2": "2.12",
          "chgp": "57.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.01",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.62",
          "val2": "1.83",
          "chgp": "43.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.56%",
          "val2": "11.39%",
          "chgp": "6.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 15.67% vs -13.73% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 11.81% vs -3.63% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.58",
          "val2": "32.49",
          "chgp": "15.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.44",
          "val2": "5.02",
          "chgp": "8.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.04",
          "val2": "0.06",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.45",
          "val2": "3.98",
          "chgp": "11.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.48%",
          "val2": "15.45%",
          "chgp": "-0.97%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -17.08% vs 13.51% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1.74% vs 9.86% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48.69",
          "val2": "58.72",
          "chgp": "-17.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.55",
          "val2": "8.60",
          "chgp": "-0.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.07",
          "val2": "0.08",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.79",
          "val2": "6.91",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.56%",
          "val2": "14.65%",
          "chgp": "2.91%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -22.51% vs 15.27% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -6.08% vs 20.37% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "66.51",
          "val2": "85.83",
          "chgp": "-22.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.61",
          "val2": "12.42",
          "chgp": "-6.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.07",
          "val2": "0.18",
          "chgp": "-61.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.27",
          "val2": "9.87",
          "chgp": "-6.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.46%",
          "val2": "14.47%",
          "chgp": "2.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
18.96
18.62
1.83%
Operating Profit (PBDIT) excl Other Income
3.33
2.12
57.08%
Interest
0.03
0.01
200.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.62
1.83
43.17%
Operating Profit Margin (Excl OI)
17.56%
11.39%
6.17%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 1.83% vs 4.49% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 43.17% vs -26.51% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
37.58
32.49
15.67%
Operating Profit (PBDIT) excl Other Income
5.44
5.02
8.37%
Interest
0.04
0.06
-33.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.45
3.98
11.81%
Operating Profit Margin (Excl OI)
14.48%
15.45%
-0.97%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 15.67% vs -13.73% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 11.81% vs -3.63% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
48.69
58.72
-17.08%
Operating Profit (PBDIT) excl Other Income
8.55
8.60
-0.58%
Interest
0.07
0.08
-12.50%
Exceptional Items
0.00
0.00
Standalone Net Profit
6.79
6.91
-1.74%
Operating Profit Margin (Excl OI)
17.56%
14.65%
2.91%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -17.08% vs 13.51% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -1.74% vs 9.86% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
66.51
85.83
-22.51%
Operating Profit (PBDIT) excl Other Income
11.61
12.42
-6.52%
Interest
0.07
0.18
-61.11%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.27
9.87
-6.08%
Operating Profit Margin (Excl OI)
17.46%
14.47%
2.99%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -22.51% vs 15.27% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -6.08% vs 20.37% in Mar 2024

stock-summaryCompany CV
About BDH Industries Ltd stock-summary
stock-summary
BDH Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Incorporated in 1990 as a private limited company, BDH Industries (BDHIL) was converted into a public limited company in 1994. It was established to take over a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of pharmaceuticals.
Company Coordinates stock-summary
Company Details
Nair Baug, Akurli Road Kandivli (E) Mumbai Maharashtra : 400101
stock-summary
Tel: 91-22-28871370/28870834
stock-summary
comp.sec@bdhind.com
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai